The combination of vemurafenib and procaspase-3 activation is synergistic in mutant BRAF melanomas

Jessie Peh, Timothy M. Fan, Kathryn L. Wycislo, Howard S. Roth, Paul J. Hergenrother

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The combination of vemurafenib and procaspase-3 activation is synergistic in mutant BRAF melanomas'. Together they form a unique fingerprint.

Medicine & Life Sciences